AstraZeneca PLC is 205.4x more valuable than Septerna, Inc. by market capitalization ($286.27 B vs $1.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SEPN | AZN |
|---|---|---|
| Market cap | $1.39 B | $286.27 B |
| US-listed rank | #2386 | #45 |
| Revenue (latest FY) | $45.95M | - |
| Net income (latest FY) | -$48.88M | - |
| Net margin | -106.4% | - |
| SEC filings | 129 | 1,004 |
AstraZeneca PLC is 205.4x more valuable than Septerna, Inc. by market capitalization ($286.27 B vs $1.39 B).
Full pages: Septerna, Inc. and AstraZeneca PLC, or browse the full rankings.